Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.46M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
524K
-
Shares change
-
+12.2K
-
Total reported value, excl. options
-
$3.67M
-
Value change
-
+$62.4K
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$7.00
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q4 2023
25 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 524K shares
of 7.46M outstanding shares and own 7.03% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (267K shares), MILLENNIUM MANAGEMENT LLC (133K shares), VANGUARD GROUP INC (28K shares), BlackRock Inc. (27.3K shares), Board of Trustees of The Leland Stanford Junior University (21.1K shares), GEODE CAPITAL MANAGEMENT, LLC (18.5K shares), RENAISSANCE TECHNOLOGIES LLC (14.1K shares), Knights of Columbus Asset Advisors LLC (4.83K shares), Tower Research Capital LLC (TRC) (4.36K shares), and BANK OF AMERICA CORP /DE/ (2.59K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.